Greater Glasgow and Clyde Medicines

Restrictions:

Restricted to specialist use in accordance with regional protocol [NHS network access required] in patients with previously untreated locally advanced or metastatic NSCLC with activating EGFR-TK mutations, i.e. as a first-line therapy.

BNF Link